{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T03:44:33Z","timestamp":1790567073648,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s00405-024-08601-4","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T11:01:53Z","timestamp":1712314913000},"page":"4175-4182","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Natural history of hearing and tumor growth in vestibular schwannoma in neurofibromatosis type 2-related schwannomatosis"],"prefix":"10.1007","volume":"281","author":[{"given":"Takeshi","family":"Wakabayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Karatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Hosoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Kanzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Toda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8204-9518","authenticated-orcid":false,"given":"Naoki","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,5]]},"reference":[{"key":"8601_CR1","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/322644a0","volume":"322","author":"BR Seizinger","year":"1986","unstructured":"Seizinger BR, Martuza RL, Gusella JF (1986) Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma. Nature 322:644\u2013647","journal-title":"Nature"},{"key":"8601_CR2","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/j.gim.2022.05.007","volume":"24","author":"SR Plotkin","year":"2022","unstructured":"Plotkin SR, Messiaen L, Legius E et al (2022) Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: an international consensus recommendation. Genet Med 24:1967\u20131977","journal-title":"Genet Med"},{"key":"8601_CR3","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/neuonc\/noaa284","volume":"23","author":"C Forde","year":"2021","unstructured":"Forde C, King AT, Rutherford SA et al (2021) Disease course of neurofibromatosis type 2: a 30-year follow-up study of 353 patients seen at a single institution. Neuro Oncol 23:1113\u20131124","journal-title":"Neuro Oncol"},{"key":"8601_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/00129492-200501000-00016","volume":"26","author":"DG Evans","year":"2005","unstructured":"Evans DG, Moran A, King A, Saeed S, Gurusinghe N, Ramsden R (2005) Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought. Otol Neurotol 26:93\u201397","journal-title":"Otol Neurotol"},{"key":"8601_CR5","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ajmg.a.33139","volume":"152A","author":"DG Evans","year":"2010","unstructured":"Evans DG, Howard E, Giblin C et al (2010) Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A 152A:327\u2013332","journal-title":"Am J Med Genet A"},{"key":"8601_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1212\/WNL.54.1.71","volume":"54","author":"J Antinheimo","year":"2000","unstructured":"Antinheimo J, Sankila R, Carp\u00e9n O, Pukkala E, Sainio M, J\u00e4\u00e4skel\u00e4inen J (2000) Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology 54:71\u201376","journal-title":"Neurology"},{"key":"8601_CR7","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1136\/jnnp-2018-318538","volume":"89","author":"DG Evans","year":"2018","unstructured":"Evans DG, Bowers NL, Tobi S et al (2018) Schwannomatosis: a genetic and epidemiological study. J Neurol Neurosurg Psychiatry 89:1215\u20131219","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8601_CR8","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/ajmg.1320520411","volume":"52","author":"DM Parry","year":"1994","unstructured":"Parry DM, Eldridge R, Kaiser-Kupfer MI, Bouzas EA, Pikus A, Patronas N (1994) Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet 52:450\u2013461","journal-title":"Am J Med Genet"},{"key":"8601_CR9","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/S0140-6736(09)60259-2","volume":"373","author":"AR Asthagiri","year":"2009","unstructured":"Asthagiri AR, Parry DM, Butman JA et al (2009) Neurofibromatosis type 2. Lancet 373:1974\u20131986","journal-title":"Lancet"},{"key":"8601_CR10","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3171\/jns.2003.99.3.0480","volume":"99","author":"G Otsuka","year":"2003","unstructured":"Otsuka G, Saito K, Nagatani T, Yoshida J (2003) Age at symptom onset and long-term survival in patients with neurofibromatosis type 2. J Neurosurg 99:480\u2013483","journal-title":"J Neurosurg"},{"key":"8601_CR11","doi-asserted-by":"publisher","first-page":"427","DOI":"10.7887\/jcns.13.427","volume":"13","author":"K Saito","year":"2004","unstructured":"Saito K (2004) Treatment of acoustic schwannomas associated with neurofibromatosis type 2. Jpn J Neurosurg 13:427\u2013432","journal-title":"Jpn J Neurosurg"},{"key":"8601_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1159\/000156905","volume":"21","author":"M Samii","year":"2008","unstructured":"Samii M, Gerganov V, Samii A (2008) Microsurgery management of vestibular schwannomas in neurofibromatosis type 2: indications and results. Prog Neurol Surg 21:169\u2013175","journal-title":"Prog Neurol Surg"},{"key":"8601_CR13","first-page":"vdaa153","volume":"3","author":"Y Ren","year":"2021","unstructured":"Ren Y, Chari DA, Vasilijic S, Welling DB, Stankovic KM (2021) New developments in neurofibromatosis type 2 and vestibular schwannoma. Neurooncol Adv. 3:vdaa153","journal-title":"Neurooncol Adv."},{"key":"8601_CR14","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1097\/MAO.0b013e31825e73f5","volume":"336","author":"SR Plotkin","year":"2012","unstructured":"Plotkin SR, Merker VL, Halpin C et al (2012) Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients. Otol Neurotol 336:1046\u20131052","journal-title":"Otol Neurotol"},{"key":"8601_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/neuonc\/nop010","volume":"121","author":"VF Mautner","year":"2010","unstructured":"Mautner VF, Nguyen R, Kutta H et al (2010) Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2. Neuro Oncol 121:14\u201318","journal-title":"Neuro Oncol"},{"key":"8601_CR16","first-page":"281","volume":"3","author":"KA Morris","year":"2016","unstructured":"Morris KA, Golding JF, Axon PR et al (2016) Bevacizumab in neurofibromatosis type 2 (NF2) related vestibular schwannomas: a nationally coordinated approach to delivery and prospective evaluation. Neurooncol Pract. 3:281\u201389","journal-title":"Neurooncol Pract."},{"key":"8601_CR17","doi-asserted-by":"publisher","first-page":"5758","DOI":"10.1038\/s41467-019-13640-1","volume":"10","author":"R Tamura","year":"2019","unstructured":"Tamura R, Fujioka M, Morimoto Y et al (2019) A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2. Nat Commun 10:5758","journal-title":"Nat Commun"},{"key":"8601_CR18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0194-5998(95)70101-X","volume":"113","author":"Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma)","year":"1995","unstructured":"Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma) (1995) American academy of otolaryngology-head and neck surgery foundation, INC. Otolaryngol Head Neck Surg. 113:179\u201380","journal-title":"Otolaryngol Head Neck Surg."},{"key":"8601_CR19","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3171\/jns.1998.88.3.0506","volume":"88","author":"WT Koos","year":"1998","unstructured":"Koos WT, Day JD, Matula C et al (1998) Neurotopographic considerations in the microsurgical treatment of small acoustic neurinomas. J Neurosurg 88:506\u2013512","journal-title":"J Neurosurg"},{"key":"8601_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046132","volume":"7","author":"AR Asthagiri","year":"2012","unstructured":"Asthagiri AR, Vasquez RA, Butman JA et al (2012) Mechanisms of hearing loss in neurofibromatosis type 2. PLoS ONE 7:e46132","journal-title":"PLoS ONE"},{"key":"8601_CR21","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1007\/s00405-014-3317-7","volume":"272","author":"G Kontorinis","year":"2015","unstructured":"Kontorinis G, Nichani J, Freeman SR et al (2015) Progress of hearing loss in neurofibromatosis type 2: implications for future management. Eur Arch Otorhinolaryngol 272:3143\u20133150","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"8601_CR22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.otc.2011.12.008","volume":"45","author":"SE Stangerup","year":"2012","unstructured":"Stangerup SE, Caye-Thomasen P (2012) Epidemiology and natural history of vestibular schwannomas. Otolaryngol Clin North Am 45:257\u2013268","journal-title":"Otolaryngol Clin North Am"},{"key":"8601_CR23","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1038\/s41598-020-80366-2","volume":"11","author":"K Wasano","year":"2021","unstructured":"Wasano K, Oishi N, Noguchi M et al (2021) Sudden sensorineural hearing loss in patients with vestibular schwannoma. Sci Rep 11:1624","journal-title":"Sci Rep"},{"key":"8601_CR24","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1097\/MAO.0000000000001019","volume":"37","author":"VL Merker","year":"2016","unstructured":"Merker VL, Bergner AL, Vranceanu AM, Muzikansky A, Slattery W 3rd, Plotkin SR (2016) Health-related quality of life of individuals with neurofibromatosis type 2: results from the NF2 natural history study. Otol Neurotol 37:574\u2013579","journal-title":"Otol Neurotol"},{"key":"8601_CR25","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.wneu.2017.07.036","volume":"106","author":"K Iwatate","year":"2017","unstructured":"Iwatate K, Yokoo K, Iwatate E et al (2017) Population characteristics and progressive disability in neurofibromatosis type 2. World Neurosurg 106:653\u2013660","journal-title":"World Neurosurg"},{"key":"8601_CR26","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/MAO.0000000000001690","volume":"39","author":"AT deTorres","year":"2018","unstructured":"deTorres AT, Brewer CC, Zalewski CK et al (2018) Audiologic natural history of small volume cochleovestibular schwannomas in neurofibromatosis type 2. Otol Neurotol 39:357\u2013364","journal-title":"Otol Neurotol"},{"key":"8601_CR27","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1097\/MAO.0b013e3181b2364c","volume":"30","author":"LM Fisher","year":"2009","unstructured":"Fisher LM, Doherty JK, Lev MH, Slattery WH (2009) Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2. Otol Neurotol 30:835\u2013841","journal-title":"Otol Neurotol"},{"key":"8601_CR28","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/MAO.0b013e318248ee02","volume":"33","author":"C Roosli","year":"2012","unstructured":"Roosli C, Linthicum FH, Cureoglu S, Merchant SN (2012) Dysfunction of the cochlea contributing to hearing loss in acoustic neuromas: an underappreciated entity. Otol Neurotol 33:473\u2013480","journal-title":"Otol Neurotol"},{"key":"8601_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/0036554021000028075","volume":"123","author":"K Graamans","year":"2003","unstructured":"Graamans K, Van Dilk JE, Janssen LW (2003) Hearing deterioration in patients with a non-growing vestibular schwannoma. Acta Otolaryngol 123:51\u201354","journal-title":"Acta Otolaryngol"},{"key":"8601_CR30","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1227\/NEU.0b013e31828bae28","volume":"72","author":"M Peyre","year":"2013","unstructured":"Peyre M, Goutagny S, Bah A et al (2013) Conservative management of bilateral vestibular schwannomas in neurofibromatosis type 2 patients: hearing and tumor growth results. Neurosurgery 72:907\u2013913","journal-title":"Neurosurgery"},{"key":"8601_CR31","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00234-009-0588-6","volume":"51","author":"M Yamazaki","year":"2009","unstructured":"Yamazaki M, Naganawa S, Kawai H, Nihashi T, Fukatsu H, Nakashima T (2009) Increased signal intensity of the cochlea on pre- and post-contrast enhanced 3D-FLAIR in patients with vestibular schwannoma. Neuroradiology 51:855\u2013863","journal-title":"Neuroradiology"},{"key":"8601_CR32","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.neuchi.2015.03.012","volume":"64","author":"M Peyre","year":"2018","unstructured":"Peyre M, Bernardeschi D, Sterkers O, Kalamarides M (2018) Natural history of vestibular schwannomas and hearing loss in NF2 patients. Neurochirurgie 64:342\u2013347","journal-title":"Neurochirurgie"},{"key":"8601_CR33","doi-asserted-by":"publisher","first-page":"18599","DOI":"10.1038\/srep18599","volume":"5","author":"S Dilwali","year":"2015","unstructured":"Dilwali S, Landegger LD, Soares VY, Deschler DG, Stankovic KM (2015) Secreted factors from human vestibular schwannomas can cause cochlear damage. Sci Rep 5:18599","journal-title":"Sci Rep"},{"key":"8601_CR34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3171\/jns.2002.96.2.0217","volume":"96","author":"ME Baser","year":"2002","unstructured":"Baser ME, Makariou EV, Parry DM (2002) Predictors of vestibular schwannoma growth in patients with neurofibromatosis type 2. J Neurosurg 96:217\u2013222","journal-title":"J Neurosurg"},{"key":"8601_CR35","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1136\/jmg.2005.031302","volume":"42","author":"ME Baser","year":"2005","unstructured":"Baser ME, Mautner VF, Parry DM, Evan DG (2005) Methodological issues in longitudinal studies: vestibular schwannoma growth rates in neurofibromatosis 2. J Med Genet 42:903\u2013906","journal-title":"J Med Genet"},{"key":"8601_CR36","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3171\/jns.2002.96.2.0223","volume":"96","author":"VF Mautner","year":"2002","unstructured":"Mautner VF, Baser ME, Thakkar SD, Feigen UM, Friedman JM, Kluwe L (2002) Vestibular schwannoma growth in patients with neurofibromatosis type 2: a longitudinal study. J Neurosurg 96:223\u2013228","journal-title":"J Neurosurg"},{"key":"8601_CR37","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10143-009-0223-3","volume":"32","author":"E Ito","year":"2009","unstructured":"Ito E, Saito K, Yatsuya H, Nagatani T, Otsuka G (2009) Factors predicting growth of vestibular schwannoma in neurofibromatosis type 2. Neurosurg Rev. 32:425\u201333","journal-title":"Neurosurg Rev."},{"key":"8601_CR38","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3171\/2012.3.JNS111649","volume":"117","author":"MS Dirks","year":"2012","unstructured":"Dirks MS, Butman JA, Kim HJ et al (2012) Long-term natural history of neurofibromatosis type 2-associated intracranial tumors. J Neurosurg. 117:109\u201317","journal-title":"J Neurosurg."},{"key":"8601_CR39","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1097\/00129492-200409000-00027","volume":"25","author":"WH Slattery 3rd","year":"2004","unstructured":"Slattery WH 3rd, Fisher LM, Iqbal Z, Oppenheimer M (2004) Vestibular schwannoma growth rates in neurofibromatosis type 2 natural history consortium subjects. Otol Neurotol. 25:811\u201317","journal-title":"Otol Neurotol."},{"key":"8601_CR40","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1097\/MAO.0000000000000239","volume":"35","author":"SR Plotkin","year":"2014","unstructured":"Plotkin SR, Merker VL, Muzikansky A, Barker FG 2nd, Slattery W 3rd (2014) Natural history of vestibular schwannoma growth and hearing decline in newly diagnosed neurofibromatosis type 2 patients. Otol Neurotol 35:e50\u2013e56","journal-title":"Otol Neurotol"},{"key":"8601_CR41","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.3390\/cancers11091376","volume":"11","author":"I Gugel","year":"2019","unstructured":"Gugel I, Grimm F, Liebsch M et al (2019) Impact of surgery on long-term results of hearing in neurofibromatosis type-2 associated vestibular schwannomas. Cancers 11:1376","journal-title":"Cancers"},{"key":"8601_CR42","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s11060-021-03910-8","volume":"156","author":"U Tosi","year":"2022","unstructured":"Tosi U, Maayan O, An A et al (2022) Stereotactic radiosurgery for vestibular schwannomas in neurofibromatosis type 2 patients: a systematic review and meta-analysis. J Neurooncol 156:431\u2013441","journal-title":"J Neurooncol"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-024-08601-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-024-08601-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-024-08601-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T08:06:53Z","timestamp":1721722013000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-024-08601-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,5]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["8601"],"URL":"https:\/\/doi.org\/10.1007\/s00405-024-08601-4","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,5]]},"assertion":[{"value":"18 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}